Sentinel Oncology is a fully integrated drug discovery company seeking to develop high quality drugs andidates for partnering with the pharmaceutical and biotechnology sectors. Their business model is collaborative and they partner with organisations who can maximise the value of our programmes.
Location: United Kingdom, England, South Hams
Investors 1
| Date | Name | Website |
| - | o2h ventur... | o2hventure... |
Mentions in press and media 5
| Date | Title | Description |
| 11.09.2024 | PhoreMost raises £33M to advance 'Drugging the Undruggable' research | PhoreMost, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, has completed an oversubscribed £33 million Series B investment round. PhoreMost’s SITESEEKER platform can identify the best new the... |
| 05.12.2008 | Report ranks Cambridge University top for transfer technology in UK to cap award-winning w... | Report ranks Cambridge University top for transfer technology in UK to cap award-winning w... 05-12-2008 A leading business research firm has ranked Cambridge University first for its technology transfer performance - in the same week as th... |
| 22.05.2007 | East of England Development Agency (EEDA) to support Sentinel Oncology in the fight agains... | East of England Development Agency (EEDA) to support Sentinel Oncology in the fight agains... 22-05-2007 Sentinel Oncology and its academic and investment partners at the University of Cambridge have received a financial boost from the East... |
| 08.02.2007 | Sentinel set to progress novel anti-cancer technology with new investment | Sentinel set to progress novel anti-cancer technology with new investment 08-02-2007 Sentinel Oncology today announces a further round of funding to progress its novel chemical technologies for developing new anticancer agents. Sentinel has... |
| 08.05.2006 | Challenge Fund invests in fight against cancer | Challenge Fund invests in fight against cancer 08-05-2006 Sentinel Oncology has received a financial boost from the Challenge Fund Trading Company, part of Cambridge Enterprise Seed Funds (CESF). Sentinel, together with Professor Ashok Venk... |